Abrdn Life Sciences Investors (HQL)

NYSE: HQL · Real-Time Price · USD

17.25

+0.15 (0.88%)

Dec 23, 2025, 4:00 PM EST - Market closed

HQL Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2015 - 2019
Net Income	85.59	-	-	-	-	Upgrade
Loss (Gain) From Sale of Investments	-88.97	-	-	-	-	Upgrade
Other Operating Activities	35.29	-	-	-	-	Upgrade
Change in Accounts Receivable	0.06	-	-	-	-	Upgrade
Change in Other Net Operating Assets	-0.26	-	-	-	-	Upgrade
Operating Cash Flow	31.71	-	-	-	-	Upgrade
Common Dividends Paid	-31.63	-	-	-	-	Upgrade
Financing Cash Flow	-31.63	-	-	-	-	Upgrade
Net Cash Flow	0.08	-	-	-	-	Upgrade
Levered Free Cash Flow	-2.18	-	-	-	-	Upgrade
Unlevered Free Cash Flow	-2.18	-	-	-	-	Upgrade
Change in Working Capital	-0.2	-	-	-	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q